Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Figg, WD; Dahut, W; Duray, P; Hamilton, M; Tompkins, A; Steinberg, SM; Jones, E; Premkumar, A; Linehan, WM; Floeter, MK; Chen, CC; Dixon, S; Kohler, DR; Kruger, EA; Gubish, E; Pluda, JM; Reed, E
   A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer
   CLINICAL CANCER RESEARCH
   
   W.D. Figg et al., "A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer", CLIN CANC R, 7(7), 2001, pp. 1888-1893
2. Rudek, MA; Figg, WD; Dyer, V; Dahut, W; Turner, ML; Steinberg, SM; Liewehr, DJ; Kohler, DR; Pluda, JM; Reed, E
   Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   M.A. Rudek et al., "Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer", J CL ONCOL, 19(2), 2001, pp. 584-592
3. Zujewski, J; Horak, ID; Bol, CJ; Woestenborghs, R; Bowden, C; End, DW; Piotrovsky, VK; Chiao, J; Belly, RT; Todd, A; Kopp, WC; Kohler, DR; Chow, C; Noone, M; Hakim, FT; Larkin, G; Gress, RE; Nussenblatt, RB; Kremer, AB; Cowan, KH
   Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   J. Zujewski et al., "Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer", J CL ONCOL, 18(4), 2000, pp. 927-941
4. Humphrey, RW; Wyvill, KM; Nguyen, BY; Shay, LE; Kohler, DR; Steinberg, SM; Ueno, T; Fukasawa, T; Shintani, M; Hayashi, H; Mitsuya, H; Yarchoan, R
   A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection
   ANTIVIRAL RESEARCH
   
   R.W. Humphrey et al., "A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection", ANTIVIR RES, 41(1), 1999, pp. 21-33
5. Kohler, DR; Krohnke, C
   Chemiluminescence as an industrial test method for antioxidant effectiveness in polyolefins: II. Versatile application aspects
   POLYMER DEGRADATION AND STABILITY
   
   D.R. Kohler e C. Krohnke, "Chemiluminescence as an industrial test method for antioxidant effectiveness in polyolefins: II. Versatile application aspects", POLYM DEGR, 63(1), 1999, pp. 165-173
6. KOHLER DR; MONTELLO MJ; GREEN L; HUNTLEY C; HIGH JL; FALLAVOLLITA A; GOLDSPIEL BR
   STANDARDIZING THE EXPRESSION AND NOMENCLATURE OF CANCER-TREATMENT REGIMENS
   American journal of health-system pharmacy
   
   D.R. Kohler et al., "STANDARDIZING THE EXPRESSION AND NOMENCLATURE OF CANCER-TREATMENT REGIMENS", American journal of health-system pharmacy, 55(2), 1998, pp. 137-144
7. KHLEIF SN; ABRAMS S; BASTIAN A; BERGMANN E; CHEN A; CHUNG Y; HAMILTON JM; KOHLER DR; MORRISON G; SCHLOM J; ALLEGRA C
   VACCINATION OF CANCER-PATIENTS CARRYING RAS MUTATIONS
   Annals of oncology
   
   S.N. Khleif et al., "VACCINATION OF CANCER-PATIENTS CARRYING RAS MUTATIONS", Annals of oncology, 9, 1998, pp. 325-325
8. WILSON WH; LITTLE R; PEARSON D; JAFFE ES; STEINBERG SM; CHESON BD; HUMPHREY R; KOHLER DR; ELWOOD P
   PHASE-II AND DOSE-ESCALATION WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR STUDY OF 9-AMINOCAMPTOTHECIN IN RELAPSED AND REFRACTORY LYMPHOMAS
   Journal of clinical oncology
   
   W.H. Wilson et al., "PHASE-II AND DOSE-ESCALATION WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR STUDY OF 9-AMINOCAMPTOTHECIN IN RELAPSED AND REFRACTORY LYMPHOMAS", Journal of clinical oncology, 16(7), 1998, pp. 2345-2351
9. KOHLER DR; KROHNKE C
   CHEMILUMINESCENCE AS AN INDUSTRIAL-TEST METHOD FOR ANTIOXIDANT EFFECTIVENESS IN POLYOLEFINS - 1 - FUNDAMENTAL CONSIDERATIONS
   Polymer degradation and stability
   
   D.R. Kohler e C. Krohnke, "CHEMILUMINESCENCE AS AN INDUSTRIAL-TEST METHOD FOR ANTIOXIDANT EFFECTIVENESS IN POLYOLEFINS - 1 - FUNDAMENTAL CONSIDERATIONS", Polymer degradation and stability, 62(2), 1998, pp. 385-393
10. TOLCHER AW; COWAN KH; NOONE MH; DENICOFF AM; KOHLER DR; GOLDSPIEL BR; BARNES CS; MCCABE M; GOSSARD MR; ZUJEWSKI J; OSHAUGHNESSY JA
    PHASE-I STUDY OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN METASTATIC BREAST-CANCER PATIENTS
    Journal of clinical oncology
    
    A.W. Tolcher et al., "PHASE-I STUDY OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN METASTATIC BREAST-CANCER PATIENTS", Journal of clinical oncology, 14(1), 1996, pp. 95-102
11. DESMET MD; STARKVANCS V; KOHLER DR; SMITH J; WITTES R; NUSSENBLATT RB
    INTRAOCULAR LEVELS OF METHOTREXATE AFTER INTRAVENOUS ADMINISTRATION
    American journal of ophthalmology
    
    M.D. Desmet et al., "INTRAOCULAR LEVELS OF METHOTREXATE AFTER INTRAVENOUS ADMINISTRATION", American journal of ophthalmology, 121(4), 1996, pp. 442-444
12. WILSON WH; JAMISDOW C; BRYANT G; BALIS FM; KLECKER RW; BATES SE; CHABNER BA; STEINBERG SM; KOHLER DR; WITTES RE
    PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY
    Journal of clinical oncology
    
    W.H. Wilson et al., "PHASE-I AND PHARMACOKINETIC STUDY OF THE MULTIDRUG-RESISTANCE MODULATOR DEXVERAPAMIL WITH EPOCH CHEMOTHERAPY", Journal of clinical oncology, 13(8), 1995, pp. 1985-1994
13. FIGG WD; THIBAULT A; COOPER MR; REID R; HEADLEE D; DAWSON N; KOHLER DR; REED E; SARTOR O
    A PHASE-I STUDY OF THE SOMATOSTATIN ANALOG SOMATULINE IN PATIENTS WITH METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER
    Cancer
    
    W.D. Figg et al., "A PHASE-I STUDY OF THE SOMATOSTATIN ANALOG SOMATULINE IN PATIENTS WITH METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER", Cancer, 75(8), 1995, pp. 2159-2164
14. THIBAULT A; SAMID D; COOPER MR; FIGG WD; TOMPKINS AC; PATRONAS N; HEADLEE DJ; KOHLER DR; VENZON DJ; MYERS CE
    PHASE-I STUDY OF PHENYLACETATE ADMINISTERED TWICE-DAILY TO PATIENTS WITH CANCER
    Cancer
    
    A. Thibault et al., "PHASE-I STUDY OF PHENYLACETATE ADMINISTERED TWICE-DAILY TO PATIENTS WITH CANCER", Cancer, 75(12), 1995, pp. 2932-2938
15. GREM JL; MCATEE N; MURPHY RF; HAMILTON JM; BALIS F; STEINBERG S; ARBUCK SG; SETSER A; JORDAN E; CHEN A; KOHLER DR; KOTITE B; ALLEGRA CJ
    PHASE-I AND PHARMACOKINETIC STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GIVEN IN COMBINATION WITH FLUOROURACIL PLUS CALCIUM LEUCOVORIN IN METASTATIC GASTROINTESTINAL ADENOCARCINOMA
    Journal of clinical oncology
    
    J.L. Grem et al., "PHASE-I AND PHARMACOKINETIC STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GIVEN IN COMBINATION WITH FLUOROURACIL PLUS CALCIUM LEUCOVORIN IN METASTATIC GASTROINTESTINAL ADENOCARCINOMA", Journal of clinical oncology, 12(3), 1994, pp. 560-568
16. KOHLER DR; GOLDSPIEL BR
    PACLITAXEL (TAXOL)
    Pharmacotherapy
    
    D.R. Kohler e B.R. Goldspiel, "PACLITAXEL (TAXOL)", Pharmacotherapy, 14(1), 1994, pp. 3-34
17. GOLDSPIEL BR; KOHLER DR
    ONDANSETRON AND METOCLOPRAMIDE FAIL TO PREVENT VOMITING SECONDARY TO ULTRA-HIGH-DOSE CISPLATIN-CARBOPLATIN CHEMOTHERAPY
    Obstetrics and gynecology
    
    B.R. Goldspiel e D.R. Kohler, "ONDANSETRON AND METOCLOPRAMIDE FAIL TO PREVENT VOMITING SECONDARY TO ULTRA-HIGH-DOSE CISPLATIN-CARBOPLATIN CHEMOTHERAPY", Obstetrics and gynecology, 84(3), 1994, pp. 483-483
18. WILSON WH; BRYANT G; BATES S; FOJO A; WITTES RE; STEINBERG SM; KOHLER DR; JAFFE ES; HERDT J; CHESON BD; CHABNER BA
    EPOCH CHEMOTHERAPY - TOXICITY AND EFFICACY IN RELAPSED AND REFRACTORYNON-HODGKINS-LYMPHOMA
    Journal of clinical oncology
    
    W.H. Wilson et al., "EPOCH CHEMOTHERAPY - TOXICITY AND EFFICACY IN RELAPSED AND REFRACTORYNON-HODGKINS-LYMPHOMA", Journal of clinical oncology, 11(8), 1993, pp. 1573-1582
19. GOLDSPIEL BR; KOHLER DR; KOUSTENIS AG; WILSON WH; TOLCHER AW; OSHAUGHNESSY JA; WITTES RE; CHABNER BA
    PACLITAXEL ADMINISTRATION USING PORTABLE INFUSION PUMPS
    Journal of clinical oncology
    
    B.R. Goldspiel et al., "PACLITAXEL ADMINISTRATION USING PORTABLE INFUSION PUMPS", Journal of clinical oncology, 11(11), 1993, pp. 2287-2288